Advertisement Australia to gain new brain research institute - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Australia to gain new brain research institute

In a bid to discover better treatments for brain disorders and create a leading neuroscience research institute, the Howard Florey Institute, Brain Research Institute and National Stroke Research Institute are to amalgamate to form a new neuroscience institute in Melbourne, Australia.

The new institute will focus on major brain and mind disorders including stroke, epilepsy, multiple sclerosis, dementia, Parkinson’s disease, addiction, schizophrenia and mood disorders.

As part of the project, the Mental Health Research Institute has decided to move from its current premises to co-locate with the yet-to-be-named new institute. The project to merge and co-locate will receive $53 million from the Victorian government, which will help fund the construction of new facilities at the University of Melbourne’s Parkville campus and at the Austin Hospital in Heidelberg.

The four research institutes will combine their world-class research skills in brain and mind disorders to establish the basis for the development of more effective treatments to combat neurological and mental disorders. Their discoveries may improve the lives of those directly, and indirectly, affected by brain and mind disorders in Australia, and around the world.

The entire project is estimated to cost over $125 million and the participants in the new institute are currently seeking further financial support.